American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

June 27, 2024

Newsletter Sponsor

Gattefossé will exhibit at CRS 2024
Sponsored by Gattefossé
Gattefossé will attend the CRS 2024 Annual Meeting and Exposition from July 8th to 12th in Bologna, Italy. Meet us at Booth #41 to keep current with our latest scientific findings. On Thursday, July 11th at 3:30 PM, attend our oral presentation on intestinal permeation, given by Philippe Caisse, Scientific Director, Gattefossé Pharmaceuticals, in collaboration with the University College Dublin. Posters on lipid excipients in hot melt extrusion and rheological characterization of lipid based topical formulations will also be presented during the week.

	Industry News

Peptide Synthesis Market Size Set to Reach $5.1 Billion in 2035
The peptide synthesis market is poised for notable expansion in the foreseeable future. This process... read more »

Novo Nordisk Selects BE&K Building Group for Major Expansion in Clayton, NC
BE&K Building Group, a leading design-build and construction management firm, is proud to announce ... read more »

Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation
Avallano, an AI-enabled clinical research company, announced the appointment of Michael A. Ibara, ... read more »

Formation Bio Secures $372MM Series D Funding to Expanding AI Drug Development Platform
Formation Bio, a tech-driven and AI-native pharma company, announced that it has raised $372MM of ... read more »

	QC Corner

Enhanced Cleanroom Control: Modern Methods for Accurate Mold Detection
In this webinar, hear from Dr. Doug Botkin from Charles River Laboratories as he discusses Enhanced ... read more »

	Cell and Gene Therapy Circuit

Advances in Electroporation Technology: Cell & Gene Therapy Development Innovations from MaxCyte
Join Mike Auerbach, editor-in-chief at American Pharmaceutical Review and Debra Barberini, PhD, ... read more »

	Infographic

Using the Carcinogenic Potency Categorization Approach (CPCA) to Classify N-nitrosamine Impurities
This infographic details the features and benefits of selecting appropriate NDSRI reference samples. read more »

	Featured Articles

		Enhancing Development Success Through a Robust Developability Assessment Tool The journey from discovery to clinical success is challenging in the complex landscape of biopharmaceutical development. One pivotal aspect that can ... read more »

		For U.S. Market Entry, Don’t Overlook Abbreviated Applications to FDA for Drugs, Biologics, and Devices The U.S. biopharma and medical device markets remain the largest and most robust in the world. The statistics on the size and potential growth of ... read more »

	Featured Video

On-Demand Webinar: What's the Impact of Fluoropolymer Use on PFAS Migration in Cell & Gene Therapy
In this webinar you’ll receive insight on common Extractable & Leachable (E&L) regulatory guidance gaps in cell & gene therapy (C>) applications. watch »

On-Demand Webinar: Analytical Considerations for the Development of Protein Therapies
This webinar will cover key aspects to consider for CMC Testing for Protein-Based Therapeutics watch »

	Featured Products

CHO-HCP ELISA Kit
Charles River Introducing the world’s first IgY based CHO-HCP ELISA kit specifically designed to close the ... learn more »

BRAND® accu-jet® S Pipette Controller
BRANDTECH® Scientific Brought to you by BRANDTECH® Scientific, the accu-jet® S pipette controller stands alone as ... learn more »

GS Camtain® Dust Collector for Pharmaceutical Applications
Camfil Air Pollution Control (APC) The Gold Series (GS) Camtain dust collector for pharmaceutical applications can be used for tablet ... learn more »

	Featured Whitepaper

Whitepaper: A General Guide to Lipid Nanoparticles
Lipid-based drug delivery (LBDD) systems are highly versatile, and have been used to deliver various bioactive molecules to targeted cells and tissues. LBDD systems have several advantages over ... read more »

Whitepaper: 4 Questions To Ask Your Fill Finish Partner To Minimize Risk And Maximize Yield
A drug developer’s fill finish partner is one of the final lines of defense before a drug product reaches the patient; thus, their commitment to mitigating risk and preventing contamination is vital... read more »

	More Products

Acconon Mixtures for Bioavailability and Emulsion Learn More
alpha300 R Confocal Raman Imaging System Learn More
Cary 5000 UV-Vis-NIR Spectrophotometer Learn More

	Directory Categories

Excipient Search Search More

Pharmaceutical Bioreactors and Fermentors Search More

Pharmaceutical and Bioprocess Filtration Systems Search More

	Events

Controlled Release Society (CRS) Annual Meeting
Bologna, Italy – 07/08/2024
The Controlled Release Society (CRS) Annual Meeting is a premier international event that brings together experts and researchers in the field of ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA